R2033155 |
RMC-4550 |
RMC-4550 is a potent, selective and allosteric inhibitor of SHP2, with an IC50 o
|
R2033156 |
G1T38;Lerociclib |
Lerociclib (G1T38) is a potent and selective inhibitor of CDK4/6, with IC50s of
|
R2033157 |
cFMS Receptor Inhibitor II |
cFMS Receptor Inhibitor II is a CSF1R kinase inhibitor.CSF-1 is a cytokine.
|
R2033158 |
MM102 |
MM-102 (HMTase Inhibitor IX) is a potent WDR5/MLL interaction inhibitor, achieve
|
R2033159 |
Pexacerfont |
Pexacerfont is a selective corticotropin-releasing factor (CRF1) receptor antago
|
R2033160 |
BAY-1895344 |
BAY-1895344 is a potent, orally available and selective ATR inhibitor, with IC50
|
R2033161 |
diABZI STING agonist-1 trihydrochloride |
diABZI STING agonist-1 (trihydrochloride) is a selective stimulator of interfero
|
R2033162 |
Bepridil hydrochloride |
Bepridil hydrochloride (CERM 1978) is a calcium channel blocker, with antiangina
|
R2033163 |
Abrocitinib |
Abrocitinib (PF-04965842) is a potent, orally active and selective JAK1 inhibito
|
R2033164 |
MG101 |
MG-101 is a potent inhibitor of cysteine proteases which inhibits calpain I, cal
|
R2033165 |
ME401 |
P110δ-IN-1 is a potent and selective inhibitor of P110δ extracted from patent WO
|
R2033166 |
BI1347 |
BI-1347 is a potent CDK8 inhibitor extracted from patent WO2017202719A1, product
|
R2033167 |
SNAP94847 |
SNAP 94847 is a novel, high affinity selective melanin-concentrating hormonerece
|
R2033168 |
A-485 |
A-485 is a potent and selective catalytic inhibitor of p300/CBP with IC50s of 9.
|
R2033169 |
Edonerpic maleate |
Edonerpic maleate is a novel neurotrophic agent which can inhibit amyloid-β pept
|
R2033170 |
Phorbol |
Phorbol is a highly toxic diterpene, whose esters have important biological prop
|
R2033171 |
JC-1 |
JC-1 is a fluorescent lipophilic carbocyanine dye used to measure mitochondrial
|
R2033172 |
Cintirorgon |
Cintirorgon (LYC-55716) is a first-in-class, selective and orally bioavailable R
|
R2033173 |
CFI-400945 |
CFI-400945 is an orally active, potent and selective polo-like kinase 4(PLK4) in
|
R2033174 |
BMS1166 |
BMS-1166 is a potent PD-1/PD-L1 interaction inhibitor with an IC50 of 1.4 nM.BMS
|
R2033175 |
VU0134992 |
VU0134992 is the first subtype-preferring, orally active and selective Kir4.1 po
|
R2033176 |
MKC3946 |
MKC3946 is a potent and soluble IRE1α inhibitor, used for cancer research.
|
R2033177 |
Palovarotene |
Palovarotene is a nuclear retinoic acid receptor γ (RAR-γ) agonist.
|
R2033178 |
CLP-290 |
CLP290 is an orally available activator of the neuron-specific K+-Cl− cotranspor
|
R2033179 |
VCE-004.8 |
VCE-004.8, a semi-synthetic multitarget cannabinoquinoid, is a specific PPARγ an
|